247 related articles for article (PubMed ID: 6695632)
1. Bromocriptine and lisuride in Parkinson's disease.
Caraceni T; Giovannini P; Parati E; Scigliano G; Grassi MP; Carella F
Adv Neurol; 1984; 40():531-5. PubMed ID: 6695632
[No Abstract] [Full Text] [Related]
2. [Oral lisuride in Parkinson's disease].
Obeso JA; Luquin MR; MartÃnez Lage JM
Med Clin (Barc); 1985 Sep; 85(8):307-12. PubMed ID: 4068822
[No Abstract] [Full Text] [Related]
3. Bromocriptine and lisuride in Parkinson disease.
Lieberman AN; Gopinathan G; Neophytides A; Leibowitz M; Walker R; Hiesiger E
Ann Neurol; 1983 Jan; 13(1):44-7. PubMed ID: 6830164
[TBL] [Abstract][Full Text] [Related]
4. Lisuride infusion pump for Parkinson's disease.
Lancet; 1986 Aug; 2(8502):348-9. PubMed ID: 2874360
[No Abstract] [Full Text] [Related]
5. Lisuride treatment in Parkinson's disease: clinical and pharmacokinetic studies.
LeWitt PA; Burns RS; Calne DB
Adv Neurol; 1983; 37():131-40. PubMed ID: 6344586
[TBL] [Abstract][Full Text] [Related]
6. Comparison between L-dopa and lisuride intravenous infusions: a clinical study.
Ruggieri S; Stocchi F; Carta A; Bravi D; Bragoni M; Giorgi L; Agnoli A
Mov Disord; 1988; 3(4):313-9. PubMed ID: 3211176
[TBL] [Abstract][Full Text] [Related]
7. [Lisuride in the combination treatment of Parkinson disease].
Jellinger K
Wien Med Wochenschr; 1987 Apr; 137(7-8):155-9. PubMed ID: 3111099
[TBL] [Abstract][Full Text] [Related]
8. [CB 154 in the treatment of Parkinson's disease. Results in combination with L-dopa and decarboxylase inhibitor].
Meco G; Casacchia M; Zamponi A; Agnoli A
Acta Neurol (Napoli); 1976; 31(4):479-48. PubMed ID: 1037427
[No Abstract] [Full Text] [Related]
9. Dopaminergic responsiveness to apomorphine after chronic treatment with subcutaneous lisuride infusion in Parkinson's disease.
Vaamonde J; Luquin MR; Obeso JA
Mov Disord; 1990; 5(3):260-2. PubMed ID: 2388647
[TBL] [Abstract][Full Text] [Related]
10. Lisuride and pergolide in Parkinson's disease.
Lang AE; Sheehy MP; Quinn NP; Brincat S; Marsden CD; Parkes D
Adv Neurol; 1983; 37():109-20. PubMed ID: 6858769
[No Abstract] [Full Text] [Related]
11. Bromocriptine: problems with low-dose de novo therapy in Parkinson's disease.
Grimes JD; Delgado MR
Clin Neuropharmacol; 1985; 8(1):73-7. PubMed ID: 3978651
[TBL] [Abstract][Full Text] [Related]
12. Bromocriptine and levodopa in early combination in Parkinson's disease: first results of the Collaborative European Multicentric Trial.
Olsson JE
Adv Neurol; 1990; 53():421-3. PubMed ID: 2239483
[No Abstract] [Full Text] [Related]
13. Chronic s.c. lisuride in Parkinson's disease--motor-performance and avoidance of psychiatric side effects.
Bittkau S; Przuntek H
J Neural Transm Suppl; 1988; 27():35-54. PubMed ID: 3165438
[TBL] [Abstract][Full Text] [Related]
14. [Effect of lisuride in the "on-off" phenomena due to L-dopa].
Piccinin GL; Piccirilli M; Rizzo PA; Agostini L
Clin Ter; 1983 Mar; 104(6):469-71. PubMed ID: 6851447
[No Abstract] [Full Text] [Related]
15. The beneficial effect of chronic lisuride administration compared with levodopa in Parkinson's disease.
Rabey JM; Streifler M; Treves T; Korczyn AD
Adv Neurol; 1990; 53():451-5. PubMed ID: 2122652
[No Abstract] [Full Text] [Related]
16. Lisuride combined with levodopa in advanced Parkinson disease.
Lieberman AN; Goldstein M; Leibowitz M; Neophytides A; Gopinathan G; Walker R; Pact V
Neurology; 1981 Nov; 31(11):1466-9. PubMed ID: 7031504
[TBL] [Abstract][Full Text] [Related]
17. [Combined therapy of parkinsonism with bromocriptine, L-dopa and decarboxylase inhibitor (author's transl)].
Vardy J; Rabey JM; Streifler M
Harefuah; 1977 Sep; 93(5-6):129-33. PubMed ID: 924233
[No Abstract] [Full Text] [Related]
18. Lisuride infusion pump for Parkinson's disease.
Lancet; 1986 May; 1(8490):1150-1. PubMed ID: 2871399
[No Abstract] [Full Text] [Related]
19. Continuous dopaminergic stimulation in the management of complicated Parkinson's disease.
Agnoli A; Stocchi F; Carta A; Antonini A; Bragoni M; Ruggieri SA
Mt Sinai J Med; 1988 Jan; 55(1):62-6. PubMed ID: 3258057
[No Abstract] [Full Text] [Related]
20. [Continuous dopaminergic stimulation in Parkinson disease].
Obeso JA; Luquin MR; Vaamonde J; Grandas F; Pastor MA; Artieda J; MartÃnez-Lage JM
Neurologia; 1987; 2(5):227-34. PubMed ID: 2908545
[No Abstract] [Full Text] [Related]
[Next] [New Search]